Medicine

HIV protection through PrEP in cisgender women

.STUDY EMPHASIZE.06 August 2024.

A huge randomized measured test along with cisgender females highlights the obstacles of fidelity to a day-to-day dental preexposure treatment program and illustrates that twice-yearly treatment of lenacapavir may keep efficient HIV prevention amounts over 6 months.